Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. is a Cell-Based Immunotherapies founded in 2020 by Kleanthis G. Xanthopoulos.
4
Funding Rounds
$229.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Kl******* G. Xa********** | - | - | - |
| St**** Ho****** | - | - | - |
Funding series
Funding Series Analysis
The company Shoreline Biosciences, Inc. has raised a total of $183m in funding over 4 rounds.
Key Insights:
- Shoreline Biosciences, Inc. Funding Round, November 2021: $140m
- Shoreline Biosciences, Inc. , April 2021: $43m
- Shoreline Biosciences, Inc. funding round, July 2020: $3m
- Shoreline Biosciences, Inc. funding round, February 2021: $43m
Shoreline Biosciences, Inc. Funding Round, November 2021
$140m
Shoreline Biosciences, Inc. , April 2021
$43m
Shoreline Biosciences, Inc. funding round, July 2020
$3m
Shoreline Biosciences, Inc. funding round, February 2021
$43m
Industries
Shoreline Biosciences, Inc. is active in the following industries: